Correlation Between Predictive Oncology and Femasys

Can any of the company-specific risk be diversified away by investing in both Predictive Oncology and Femasys at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Predictive Oncology and Femasys into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Predictive Oncology and Femasys, you can compare the effects of market volatilities on Predictive Oncology and Femasys and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Predictive Oncology with a short position of Femasys. Check out your portfolio center. Please also check ongoing floating volatility patterns of Predictive Oncology and Femasys.

Diversification Opportunities for Predictive Oncology and Femasys

0.17

Correlation Coefficient

Predictive Oncology  Femasys

Average diversification

The 3 months correlation between Predictive and Femasys is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Predictive Oncology and Femasys in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Femasys and Predictive Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Predictive Oncology are associated (or correlated) with Femasys. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Femasys has no effect on the direction of Predictive Oncology i.e., Predictive Oncology and Femasys go up and down completely randomly.

Pair Corralation between Predictive Oncology and Femasys

Given the investment horizon of 90 days Predictive Oncology is expected to generate 2.73 times more return on investment than Femasys. However, Predictive Oncology is 2.73 times more volatile than Femasys. It trades about 0.11 of its potential returns per unit of risk. Femasys is currently generating about 0.08 per unit of risk. If you would invest  90.00  in Predictive Oncology on December 30, 2024 and sell it today you would earn a total of  55.00  from holding Predictive Oncology or generate 61.11% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Predictive Oncology  vs.  Femasys

Predictive Oncology

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Predictive Oncology are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite fairly conflicting basic indicators, Predictive Oncology demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Femasys

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Femasys are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak primary indicators, Femasys showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Predictive Oncology and Femasys

The main advantage of trading using opposite Predictive Oncology and Femasys positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Predictive Oncology position performs unexpectedly, Femasys can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Femasys will offset losses from the drop in Femasys' long position.

The idea behind Predictive Oncology and Femasys pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.